Treatment of Lennox-Gastaut Syndrome (LGS)

European Journal of Paediatric Neurology

Volumn 13, Issue 6, 2009, Pages 493-504

  Ferrie, Colin D ^a   Patel, Amit ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b EISAI CO LTD   (Japan)

Author keywords

Antiepileptic drug; Child; Epilepsy; Epileptic encephalopathy; Management

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BROMIDE; CARBAMAZEPINE; CINROMIDE; CLOBAZAM; CORTICOSTEROID; CORTICOTROPIN DERIVATIVE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; IMMUNOGLOBULIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREDNISONE; PRIMIDONE; RUFINAMIDE; TETRACOSACTIDE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE; ADD ON THERAPY; AGITATION; ANOREXIA; APLASTIC ANEMIA; ATAXIA; ATONIC SEIZURE; BEHAVIOR CHANGE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DELIRIUM; DISEASE SEVERITY; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FATIGUE; FEVER; FOCAL EPILEPSY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS; HUMAN; HYPERACTIVITY; HYPERSALIVATION; IDIOPATHIC DISEASE; INFECTION; IRRITABILITY; KETOGENIC DIET; LANGUAGE DISABILITY; LEARNING DISORDER; LENNOX GASTAUT SYNDROME; LIVER FAILURE; MENTAL DEFICIENCY; MYOCLONUS SEIZURE; NAUSEA; NERVOUSNESS; OBSERVATIONAL STUDY; OPEN STUDY; PANCREATITIS; PRIORITY JOURNAL; PROGNOSIS; RASH; RETROSPECTIVE STUDY; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SKIN MANIFESTATION; SLEEP DISORDER; SLOW BRAIN WAVE; SOMNOLENCE; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VISUAL DISORDER; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ANTICONVULSANTS; COGNITION DISORDERS; CORPUS CALLOSUM; DIET THERAPY; DOUBLE-BLIND METHOD; EPILEPSY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VAGUS NERVE STIMULATION;

EID: 68749111361     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2008.12.005     Document Type: Review

References (86)

1. Tidy C. Lennox-Gastaut Syndrome (24 Nov 2004), EMIS. http://www.patient.co.uk/showdoc/40001739 [accessed 5.03.07]
2. Cavazzuti G.B. Epidemiology of different types of epilepsy in school age children of Modena, Italy. Epilepsia 21 1 (1980) 57-62
3. Trevathan E., Murphy C.C., and Yeargin-Allsopp M. Prevalence and descriptive epidemiology of Lennox-Gastaut Syndrome among Atlanta children. Epilepsia 38 12 (1997) 1283-1288
4. Sidenvall R., Forsgren L., and Heijbel J. Prevalence and characteristics of epilepsy in children in northern Sweden. Seizure 5 2 (1996) 139-146
5. Markand O.N. Lennox-Gastaut Syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 20 6 (2003) 426-441
6. Stephani U. The natural history of myoclonic astatic epilepsy (Doose syndrome) and Lennox-Gastaut Syndrome. Epilepsia 47 Suppl. 2 (2006) 53-55
7. Bladin P.F. Adult Lennox Gastaut syndrome: features and diagnostic problems. Clin Exp Neurol 21 (1985) 93-104
8. Bladin P.F. Adult Lennox Gastaut syndrome: patients with large focal structural lesions. Clin Exp Neurol 21 (1985) 105-114
9. Trevathan E. Infantile spasms and Lennox-Gastaut Syndrome. J Child Neurol 17 Suppl. 2 (2002) 2S9-22
10. Niedermeyer E. Lennox-Gastaut Syndrome. Clinical description and diagnosis. Adv Exp Med Biol 497 (2002) 61-75
11. Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl 6 (1992) 163-168
12. ILAE. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 30 4 (1989) 389-399
13. Engel Jr. J. Classification of epileptic disorders. Epilepsia 42 3 (2001) 316
14. Appleton R. Lennox-Gastaut Syndrome (January 5, 2007), British Epilepsy Association. http://www.epilepsy.org.uk/info/lennox.html [accessed 5.03.07]
15. Quarato P.P., Gennaro G.D., Manfredi M., and Esposito V. Atypical Lennox-Gastaut Syndrome successfully treated with removal of a parietal dysembryoplastic tumour. Seizure 11 5 (2002) 325-329
16. Oguni H., Hayashi K., and Osawa M. Long-term prognosis of Lennox-Gastaut Syndrome. Epilepsia 37 Suppl. 3 (1996) 44-47
17. Hoffmann-Riem M., Diener W., Benninger C., et al. Nonconvulsive status epilepticus - a possible cause of mental retardation in patients with Lennox-Gastaut Syndrome. Neuropediatrics 31 4 (2000) 169-174
18. Hancock E., and Cross H. Treatment of Lennox-Gastaut Syndrome. Cochrane Database Syst Rev 3 (2003) CD003277
19. The Group for the Evaluation of Cinromide in the Lennox-Gastaut Syndrome. Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome. Epilepsia 30 4 (1989) 422-429
20. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut Syndrome). N Engl J Med 328 1 (1993) 29-33
21. Motte J., Trevathan E., Arvidsson J.F., et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut Syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 337 25 (1997) 1807-1812
22. Sachdeo R.C., Glauser T.A., Ritter F., et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut Syndrome. Topiramate YL Study Group. Neurology 52 9 (1999) 1882-1887
23. Glauser T, Kluger G, Sachdeo R, et al. Rufinamide for generalised seizures associated with Lennox-Gastaut syndrome 2008; 70(21):1950-8.
24. Glauser T., Ben-Menachem E., Bourgeois B., et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47 7 (2006) 1094-1120
25. Theodore W.H., Jensen P.K., and Kwan R.M.F. Felbamate: clinical use. 4th ed. (1995), Raven Press, New York Levy RJ, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs
26. Bourgeois B.F. Felbamate. Semin Pediatr Neurol 4 1 (1997) 3-8
27. Hommes O.R., and Obbens E.A. The epileptogenic action of Na-valproate in the rat. J Neurol Sci 16 3 (1972) 271-281
28. British National Formulary. British National Formulary 53 (March 2007) (2007), BMJ Publishing Group and RPS Publishing, London
29. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28 3 (1997) 167-179
30. Arroyo S. Rufinamide. Neurotherapeutics 4 1 (2007) 155-162
31. Chamberlain M.C. Nitrazepam for refractory infantile spasms and the Lennox-Gastaut Syndrome. J Child Neurol 11 1 (1996) 31-34
32. Munn R., and Farrell K. Open study of clobazam in refractory epilepsy. Pediatr Neurol 9 6 (1993) 465-469
33. Schmidt D. How to use benzodiazepines. In: Morselli P.L., Pippenger C.E., and Penry J.K. (Eds). Antiepileptic drug therapy in paediatrics (1983), Raven Press, New York 271-278
34. Bittencourt P.R., and Richens A. Anticonvulsant-induced status epilepticus in Lennox-Gastaut Syndrome. Epilepsia 22 1 (1981) 129-134
35. Farrell K. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 27 Suppl. 1 (1986) S45-S52
36. Jan M.M., and Shaabat A.O. Clobazam for the treatment of intractable childhood epilepsy. Saudi Med J 21 7 (2000) 622-624
37. Ryan M., and Baumann R.J. Use and monitoring of bromides in epilepsy treatment. Pediatr Neurol 21 2 (1999) 523-528
38. Boenigk H.E., Saelke-Treumann A., May T., and Juergens U. Bromides: useful for treatment of generalized epilepsies in children and adolescents?. Cleve Clin J Med 56 (1989) S272
39. Woody R.C. Bromide therapy for pediatric seizure disorder intractable to other antiepileptic drugs. J Child Neurol 5 1 (1990) 65-67
40. Horn C.S., Ater S.B., and Hurst D.L. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 2 6 (1986) 340-345
41. Dodson W.E. Felbamate in the treatment of Lennox-Gastaut Syndrome: results of a 12-month open-label study following a randomized clinical trial. Epilepsia 34 Suppl. 7 (1993) S18-S24
42. Siegel H., Kelley K., Stertz B., et al. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut Syndrome. Epilepsy Res 34 2-3 (1999) 91-97
43. Cilio M.R., Kartashov A.I., and Vigevano F. The long-term use of felbamate in children with severe refractory epilepsy. Epilepsy Res 47 1-2 (2001) 1-7
44. Kaufman D.W., Kelly J.P., Anderson T., Harmon D.C., and Shapiro S. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 38 12 (1997) 1265-1269
45. Timmings P.L., and Richens A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut Syndrome. Eur Neurol 32 6 (1992) 305-307
46. Schlumberger E., Chavez F., Palacios L., et al. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 35 2 (1994) 359-367
47. Uvebrant P., and Bauziene R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 25 6 (1994) 284-289
48. Buchanan N. Lamotrigine: clinical experience in 93 patients with epilepsy. Acta Neurol Scand 92 1 (1995) 28-32
49. Farrell K., Connolly M.B., Munn R., Peng S., and MacWilliam L.M. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Pediatr Neurol 16 3 (1997) 201-205
50. Donaldson J.A., Glauser T.A., and Olberding L.S. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut Syndrome). Epilepsia 38 1 (1997) 68-73
51. Eriksson A.S., Nergardh A., and Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia 39 5 (1998) 495-501
52. Ferrie C.D., Robinson R.O., Knott C., and Panayiotopoulos C.P. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 91 3 (1995) 200-202
53. Labate A., Colosimo E., Gambardella A., et al. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure 15 3 (2006) 214-218
54. Weber S., and Beran R.G. A pilot study of compassionate use of levetiracetam in patients with generalised epilepsy. J Clin Neurosci 11 7 (2004) 728-731
55. De Los Reyes E.C., Sharp G.B., Williams J.P., and Hale S.E. Levetiracetam in the treatment of Lennox-Gastaut Syndrome. Pediatr Neurol 30 4 (2004) 254-256
56. Deeks E.D., and Scott L.J. Rufinamide. CNS Drugs 20 9 (2006) 751-760 [discussion 61]
57. Jeavons P.M., Clark J.E., and Maheshwari M.C. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim"). Dev Med Child Neurol 19 1 (1977) 9-25
58. Schmidt D. Adverse effects of valproate. Epilepsia 25 Suppl. 1 (1984) S44-S49
59. Glauser T.A., Levisohn P.M., Ritter F., and Sachdeo R.C. Topiramate in Lennox-Gastaut Syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Epilepsia 41 Suppl. 1 (2000) S86-S90
60. Glauser T.A. Preliminary observations on topiramate in pediatric epilepsies. Epilepsia 38 Suppl. 1 (1997) S37-S41
61. Coppola G., Caliendo G., Veggiotti P., et al. Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut Syndrome: an Italian multicentric study. Epilepsy Res 51 1-2 (2002) 147-153
62. Al Ajlouni S., Shorman A., and Daoud A.S. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial. Seizure 14 7 (2005) 459-463
63. Grosso S., Franzoni E., Iannetti P., et al. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study. J Child Neurol 20 11 (2005) 893-897
64. Livingston J.H., Beaumont D., Arzimanoglou A., and Aicardi J. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 27 Suppl. 1 (1989) 109S-112S
65. Luna D., Dulac O., Pajot N., and Beaumont D. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 30 4 (1989) 430-437
66. Feucht M., and Brantner-Inthaler S. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut Syndrome: an open study. Epilepsia 35 5 (1994) 993-998
67. Harding G.F., Robertson K., Spencer E.L., and Holliday I. Vigabatrin; its effect on the electrophysiology of vision. Doc Ophthalmol 104 2 (2002) 213-229
68. Yamauchi T., and Aikawa H. Efficacy of zonisamide: our experience. Seizure 13 Suppl. 1 (2004) S41-S48 [discussion S9]
69. Gupta R., and Appleton R. Corticosteroids in the management of the paediatric epilepsies. Arch Dis Child 90 4 (2005) 379-384
70. Yamatogi Y., Ohtsuka Y., Ishida T., et al. Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev 1 4 (1979) 267-276
71. O'Regan M.E., and Brown J.K. Is ACTH a key to understanding anticonvulsant action?. Dev Med Child Neurol 40 2 (1998) 82-89
72. Sinclair D.B. Prednisone therapy in pediatric epilepsy. Pediatr Neurol 28 3 (2003) 194-198
73. Gross-Tsur V., Shalev R.S., Kazir E., Engelhard D., and Amir N. Intravenous high-dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand 88 3 (1993) 204-209
74. Illum N., Taudorf K., Heilmann C., et al. Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut Syndrome. Neuropediatrics 21 2 (1990) 87-90
75. van Rijckevorsel-Harmant K., Delire M., and Rucquoy-Ponsar M. Treatment of idiopathic West and Lennox-Gastaut Syndromes by intravenous administration of human polyvalent immunoglobulins. Eur Arch Psychiatry Neurol Sci 236 2 (1986) 119-122
76. Neal E.G., Chaffe H.M., Edwards N., et al. The ketogenic diet in the treatment of epilepsy in children: a randomised controlled trial. Lancet Neurology 7 6 (2008) 500-506
77. Henderson C.B., Filloux F.M., Alder S.C., Lyon J.L., and Caplin D.A. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol 21 3 (2006) 193-198
78. Hartman A.L. Does the effectiveness of the ketogenic diet in different epilepsies yield insight into its mechanisms?. Epilepsia 49 Suppl. 8 (2008) 53-56
79. Kang H.C., Chung D.E., Kim D.W., and Kim H.D. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 45 9 (2004) 1116-1123
80. Wong T.T., Kwan S.Y., Chang K.P., et al. Corpus callosotomy in children. Childs Nerv Syst 22 8 (2006) 999-1011
81. Maehara T., and Shimizu H. Surgical outcome of corpus callosotomy in patients with drop attacks. Epilepsia 42 1 (2001) 67-71
82. Karceski S. Vagus nerve stimulation and Lennox-Gastaut Syndrome: a review of the literature and data from the VNS patient registry. CNS Spectr 6 9 (2001) 766-770
83. Nice. Clinical Guideline 20. The epilepsies. The diagnosis and management of the epilepsies in adults and children in primary and secondary care (October 2004), National Institute of Clinical Excellence, London Developed by the National Collaborating Centre for Primary Care
84. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 8 (2004) 1261-1273
85. Guerrini R., Belmonte A., and Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 39 Suppl. 3 (1998) S2-S10
86. Biraben A., Allain H., Scarabin J.M., Schuck S., and Edan G. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 55 11 (2000) 1758